Little Green Pharma (ASX:LGP) FCF Margin %: -2.99% (As of Mar. 2026)


What is Little Green Pharma FCF Margin %?

Little Green Pharma ASX:LGP FCF Margin % is -2.99% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 958 Drug Manufacturers companies, Little Green Pharma ranks worse than 62.84% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Little Green Pharma's Free Cash Flow for the six months ended in Mar. 2026 was A$-0.70 Mil. Little Green Pharma's Revenue for the six months ended in Mar. 2026 was A$23.24 Mil. Therefore, Little Green Pharma's FCF Margin % for the quarter that ended in Mar. 2026 was -2.99%.

As of today, Little Green Pharma's current FCF Yield % is -1.83%.

The historical rank and industry rank for Little Green Pharma's FCF Margin % or its related term are showing as below:

ASX:LGP' s FCF Margin % Range Over the Past 10 Years
Min: -583.48   Med: -33.02   Max: -2.26
Current: -2.26

During the past 7 years, the highest FCF Margin % of Little Green Pharma was -2.26%. The lowest was -583.48%. And the median was -33.02%.

ASX:LGP's FCF Margin % is ranked worse than
62.84% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs ASX:LGP: -2.26

Little Green Pharma FCF Margin % Related Terms

Little Green Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma FCF Margin % Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial -88.68 -60.66 -5.37 -4.46 -2.26

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 1.43 -9.81 -1.38 -2.99

ASX:LGP vs ZTS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's FCF Margin % falls into.


Little Green Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Little Green Pharma's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-0.96/42.425
=-2.26 %

Little Green Pharma's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.696/23.243
=-2.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -2.99% mean?
Little Green Pharma (ASX:LGP) has a FCF Margin % of -2.99% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Little Green Pharma and its competitors. According to the industry distribution chart, Little Green Pharma ranks #602 out of 958 companies in the Drug Manufacturers industry, placing it in the top 62.8%.
Is Little Green Pharma's FCF Margin % too high?
Little Green Pharma's current FCF Margin % is -2.99%. Based on the distribution chart, Little Green Pharma ranks #602 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Little Green Pharma's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #602 out of 958 companies for FCF Margin %. This places Little Green Pharma in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Little Green Pharma and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current FCF Margin % is -2.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.4% below its estimated fair value. The current FCF Margin % is -2.99%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current FCF Margin % is -2.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).